Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
Blood transfusion and the transmission of cytomegalovirus
Kevin Walsh, R. Armstrong, A. Turner (1988)
Brachial plexus neuropathy associated with human parvovirus infectionBritish Medical Journal (Clinical research ed.), 296
(1992)
Human parvovirus B 19 in clotting factor Concentrates : B 19 DNA detection by the nested polymerase chain reaction
(1988)
Absence of hepatitis , HIV and low incidence of parvovirus antibodies in virgin haemophiliac boys after treatment with British NHS heat treated factor VIII concentrate ( 8 Y ) ( abstract )
H. Faden, G. Gary, Larry Anderson (1992)
Chronic parvovirus infection in a presumably immunologically healthy woman.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 15 4
J. Clarke (1907)
MedicineBristol Medico-Chirurgical Journal (1883), 25
(1993)
Detection of parvovirus B 19 in donated blood : a model system for screening by polymerase chain reaction
B. Cohen, A. Field, S. Gudnadóttir, S. Beard, J. Barbara (1990)
Blood donor screening for parvovirus B19.Journal of virological methods, 30 3
Corman Corman, Dolson Dolson (1992)
Polyarteritis nodosa and parvovirus B19 infection (letter)Lancet, 339
Azzi Azzi, Fanci Fanci, Ciappi Ciappi, Zakrzewska Zakrzewska, Bosi Bosi (1993)
Human parvovirus B19 infection in bone marrow transplantationAm J Hematol, 44
J. Lefrère, A. Couroucé, J. Muller, M. Clark, J. Soulier, P. Mortimer, B. Cohen, M. Rossiter, S. Fairhead, A. Rahman (1985)
HUMAN PARVOVIRUS AND PURPURAThe Lancet, 326
(1989)
Prolonged parvovirus B 19 infection with severe anaemia in a bone marrow transplant patient ( letter )
Azzi Azzi, Ciappi Ciappi, Zakrzewska Zakrzewska, Morfini Morfini, Mariani Mariani, Mannucci Mannucci (1992)
Human parvovirus B19 infection in hemophiliacs first infused with high purity, virally attenuated factor VIII concentratesAm J Hematol, 39
M. Williams, B. Cohen, A. Beddall, K. Pasi, P. Mortimer, F. Hill (1990)
Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 58
M. Musiani, A. Azzi, M. Zerbini, D. Gibellini, S. Venturoli, K. Zakrzewska, M. Re, G. Gentilomi, G. Gallinella, M. Placa (1993)
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patientsJournal of Medical Virology, 40
N. Luban (1994)
Human parvoviruses: implications for transfusion medicineTransfusion, 34
D. Borreda, S. Palomera, B. Gilbert, A. Lienhardt, L. Lumley (1992)
[24 cases of human parvovirus B19 infection in children].Annales de pediatrie, 39 9
G. Serjeant, B. Serjeant (1993)
Management of sickle cell disease; lessons from the Jamaican Cohort Study.Blood reviews, 7 3
M. Anderson, P. Higgins, L. Davis, J. Willman, S. Jones, I. Kidd, J. Pattison, D. Tyrrell (1985)
Experimental parvoviral infection in humans.The Journal of infectious diseases, 152 2
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
Lyon Lyon, Chapman Chapman, Martin Martin (1989)
Symptomatic parvovirus B19 infection and heat‐treated factor DC concentrate (letter)Lancet, 1
K. Brown, S. Anderson, N. Young (1993)
Erythrocyte P antigen: cellular receptor for B19 parvovirus.Science, 262 5130
K. McClain, Z. Estrov, Hong Chen, D. Mahoney (1993)
Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studiesBritish Journal of Haematology, 85
S. Dietrich, J. Mosley, J. Lusher, M. Hilgartner, E. Operskalski, L. Habel, L. Aledort, G. Gjerset, M. Koerper, B. Lewis, C. Pegelow (1990)
Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates 1Vox Sanguinis, 59
G. Kurtzman, N. Frickhofen, J. Kimball, D. Jenkins, A. Nienhuis, N. Young (1989)
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.The New England journal of medicine, 321 8
O. Corsi, A. Azzi, M. Morfini, R. Fanci, P. Ferrini (1988)
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 25
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
J. Garson, F. Preston, M. Makris, P. Tuke, C. Ring, S. Machin, R. Tedder (1990)
Detection by PCR of hepatitis C virus in factor VIII concentratesThe Lancet, 335
N. Frickhofen, J. Abkowitz, M. Safford, J. Berry, J. Antunez-de-Mayolo, A. Astrow, Robert Cohen, I. Halperin, L. King, D. Mintzer, B. Cohen, N. Young (1990)
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.Annals of internal medicine, 113 12
Lefrére Lefrére, Mariotti Mariotti, Thauvin Thauvin (1994)
B19 parvovirus DNA in solvent/detergent‐treated anti‐haemophilia concentratesLancet, 343
D. Horn, P. Mortimer, N. Young, G. Hanson (1986)
Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia.The American journal of pediatric hematology/oncology, 8 3
Should measures be taken to reduce the risk of human parvovirus (B 19) infection by transfusion of blood components and clotting factor concentrates? Over the last several years, a seemingly endless array of infectious agents have occasionally been transmitted by blood components andor plasma derivatives. We had thought that human parvovirus (HPV, B19) was responsible only for a self-limited common childhoodexanthem, with a brief period of viremia. It is now known to be a virus that is capable of prolonged viremia,' latency with reactivation,2and possible reinfe~tion.~.~ proporA small tion of persons have serious, sometimes chronic, impaired production of erythroid and, sporadically, other bone marrow cells, as well as manifestations in other systems. In this issue of TRANSFUSION, Luban5makes clear that a great deal can be learned quickly about a virus and its pathogenesis by using the tools of molecular virology. She correctly points out how much more difficult is the definition of the type and variety of recipients for whom HPV infection has the potential to be clinically important. Definition of the number of serious acute and chronic HPV cases, particularly if they are sporadic, depends first upon the physician's being aware of the possible diagnosis. In addition,
Transfusion – Wiley
Published: Sep 1, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.